Navigation Links
Erchonia’s NEW FX 635 Laser for Chronic Low Back Pain will be Available at The National 2018
Date:8/15/2018

The Florida Chiropractic Association’s National Meeting on August 16th-19th in Orlando, FL will be the NEW FX 635 Laser’s unveiling. Doctors from around the U.S. will gain firsthand insights into the new laser’s advancements and superior treatment abilities.

With the NEW FX 635, Erchonia Corporation completed another successful clinical trial that has resulted in the granting of an FDA 510(k) market clearance for chronic low back pain of musculoskeletal origin. This grants another first for Erchonia, which started the low-level laser category in January 2002. That year, the FDA issued its first 510(k) market clearance for any low-level laser based on Erchonia’s clinical trial for chronic neck and shoulder pain.

This new indication for chronic low back pain is the only laser to be market cleared by the FDA. Erchonia’s long history and dedication to the science of low-level laser therapy has led to 15 FDA 510(k) market clearances based on their patented lasers.

About the study: Erchonia through the pre-IDE process worked with the U.S. FDA on study design and success criteria. The success criteria were defined as a minimum of a 30% decrease in chronic low back pain and 35% of patients in the treated group would experience the minimum pain reduction compared to the placebo group. Overall, 72% of patients met the success criteria. Steven Shanks, President of Erchonia stated, “We believe we have demonstrated that the use of non-thermal lasers has proven to be a far better option for treating low back pain than that of opioids or NSAIDS.”

A recent study published in JAMA in 2018 titled "The Space Randomized Clinical Trial" looked at chronic low back pain with opioids and NSAIDS over 1 year. Opioids demonstrated a 30% reduction in pain and NSAIDS proved a 34.5% reduction in pain. The publication concluded that “Results do not support initiation of opioid therapy for moderate to severe back pain or hip or knee osteo arthritis pain”.

Taking into consideration the minimal effectiveness (30%) and the opioid crisis along with the side effects of NSAIDS for chronic low back pain, doctors and patients may now have safer, more effective option for chronic low back pain of musculoskeletal origin that has been proven successful with no side effects or adverse events.

Erchonia would like to thank Doctors Greg Roche, Trevor Berry and Paul Quarneri for their dedication to the science of low-level laser therapy and for helping them document this placebo-controlled, randomized, double-blind, parallel group, multi-center clinical study.

For more information, please visit http://www.erchonia.com.

About Erchonia

A small family company is changing the world with the most advanced non-invasive lasers on the market. Erchonia went from starting in a small garage in 1996 to selling their product in over 50 different countries around the world in 2018. Erchonia has been passionate about researching and developing low level lasers since the beginning with over (15) FDA clearances for treating chronic pain and promoting fat loss. As this family has grown so has the world of non-invasive drug-free healthcare solutions.

Read the full story at https://www.prweb.com/releases/erchonias_new_fx_635_laser_for_chronic_low_back_pain_will_be_available_at_the_national_2018/prweb15694383.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Improved material for laser welding of tissue in intestinal surgery
2. CLEO: 2013 -- the Premier International Laser and Electro-Optics Event in San Jose next week
3. CLEO: 2013 press luncheon spotlights new techniques in optofluidics, temporal cloaking, cryolasers
4. LaserLock Technologies Moves Forward With An Even More Secure Multi-Factor Internet/Mobile Login System
5. LaserLock Technologies Files A New Provisional Patent Which Secures Player Identity On Internet Gaming Platforms
6. Information conveyed to urologists regarding laser fiber diameter is incorrect, says new study
7. Laser technology sorting method can improve Capsicum pepper seed quality
8. Lasers offer an automated way to test drinking water
9. Lasers might be the cure for brain diseases such as Alzheimers and Parkinsons
10. Scientists prove X-ray laser can solve protein structures from scratch
11. Fighting cancer with lasers and nanoballoons that pop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2018)... Calif. (PRWEB) , ... August 21, 2018 , ... ... engineer the genomes of diverse cell types and species for the robust functional ... research tool for the development of T-cell based immunotherapies, the study of the ...
(Date:8/23/2018)... ... ... is proud to have hosted a variety of groups this year – both new guests ... Hewlett Packard, Sequenom and more, have all visited the La Jolla-based venue time and time ... reason clientele return is due to Lajollacooks4u’s signature team-building format, a way for teams to ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics , a ... Aptevo will use the Genedata Biologics ® platform to facilitate expansion ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more ... and getting connected, too. Draper’s latest system is tiny in size, but is poised ... driving factor in the new implant design is the growing awareness that disease often ...
(Date:8/29/2018)... ... August 28, 2018 , ... Inc. Magazine has announced that ... in 1138th place on the 27th annual Inc. 5000, the most prestigious ranking ... most successful companies within the American economy’s most dynamic segment – independent small ...
(Date:8/29/2018)... SANTA BARBARA, Calif. (PRWEB) , ... August 28, 2018 , ... ... process optimization firm for the life sciences and healthcare industries, announces that Manu Vohra ... CA on August 30th. , What: “How to Implement Box for GxP in ...
(Date:8/23/2018)... , ... August 22, 2018 , ... ... for Android on September 1st, making it the first fully-featured app for electronic ... Android devices. Combined, iOS and Android constitute 99 percent of the market share ...
Breaking Biology Technology: